Protalix BioTherapeutics, Inc.: Form 10-Q/A for the period ended Mar 31, 2020
Filed with the SEC on Jun 1, 2020 and accepted by EDGAR at Jun 1, 2020, 17:20 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-20-068485. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.